Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Thermo Fisher Scientific (TMO) just posted third-quarter results that came in ahead of expectations, showing healthy revenue ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

Michael O'Connell, Chief Analytics Officer at Spotfire, on his journey to technology leadership in energy management ...

Called the photovoltaic retina implant microarray (PRIMA), the small system uses a subretinal ... The researchers said they ...

This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and ...

Good drugs are potent and specific; that is, they must have strong effects on a specific biological pathway and minimal effects on all other pathways. Confirmation that a compound inhibits the ...

AI translates electrical signals to the brain to help restore reading vision to treat a common form of blindness that was ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...